Abstracts:Background: Pediatric atopic dermatitis (AD) can pose a significant financial burden to families. However, no studies exist that assess the impact of pediatric AD on health care access/affordability at the parental level.
Objective: Explore the effects of childhood AD on parental access to health care and the socioeconomic factors that might exacerbate these problems.
Methods:
The National Health Interview Survey was used to analyze 48,329,314 participants who answered the validated question on pediatric AD. Multivariable logistic regression analyses were performed to assess the association between pediatric AD and parental access to care.
Results:
Parents of children with AD were more likely to have difficulty accessing prescription medications (aOR: 1.47; [95% CI 1.31–1.65]), follow-up care (1.36; [95% CI 1.17–1.57]), specialist care (aOR: 1.53; [95% CI 1.33–1.75]), and more likely to purchase medications from abroad (aOR: 1.35; [95% CI 1.09–1.67]) relative to their counterparts with children without AD. Within the AD cohort, uninsured or lower income participants had higher odds of facing these barriers to care.
Conclusions:
Parents of children with AD are more likely to face barriers in health care access, and significant disparities exist based on sociodemographic characteristics.
Get full access to this article
View all access options for this article.
References
1.
SilverbergJI. Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol. 2019; 123(2):144–151; doi: 10.1016/J.ANAI.2019.04.020
2.
HuaT, SilverbergJI. Atopic dermatitis in US adults: Epidemiology, association with marital status, and atopy. Ann Allergy Asthma Immunol. 2018; 121(5):622–624; doi: 10.1016/J.ANAI.2018.07.019
3.
SilverbergJI, BarbarotS, GadkariA, et al.Atopic dermatitis in the pediatric population: A cross-sectional, international epidemiologic study. Ann Allergy Asthma Immunol. 2021; 126(4):417–428.e2; doi: 10.1016/J.ANAI.2020.12.020
KantorR, ThyssenJP, PallerAS, et al.Atopic dermatitis, atopic eczema, or eczema? A systematic review, meta-analysis, and recommendation for uniform use of ‘atopic dermatitis.’ Allergy. 2016; 71(10):1480–1485; doi: 10.1111/ALL.12982
6.
OyoshiMK, HeR, KumarL, et al.Chapter 3 cellular and molecular mechanisms in atopic dermatitis. Adv Immunol. 2009; 102:135–226; doi: 10.1016/S0065-2776(09)01203-6
RamirezFD, ChenS, LanganSM, et al.Association of atopic dermatitis with sleep quality in children. JAMA Pediatr. 2019; 173(5):e190025-e190025; doi: 10.1001/JAMAPEDIATRICS.2019.0025
9.
ChangYS, ChiangBL. Sleep disorders and atopic dermatitis: A 2-way street? J Allergy Clin Immunol. 2018; 142(4):1033–1040; doi: 10.1016/J.JACI.2018.08.005
10.
VittrupI, AndersenYMF, SkovL, et al.The association between atopic dermatitis, cognitive function and school performance in children and young adults. Br J Dermatol. 2023; 188(3):341–349; doi: 10.1093/BJD/LJAC058
11.
WanJ, TakeshitaJ, ShinDB, et al.Mental health impairment among children with atopic dermatitis: A United States population-based cross-sectional study of the 2013-2017 National Health Interview Survey. J Am Acad Dermatol. 2020; 82(6):1368–1375; doi: 10.1016/J.JAAD.2019.10.019
12.
ChengBT, SilverbergJI. Association of pediatric atopic dermatitis and psoriasis with school absenteeism and parental work absenteeism: A cross-sectional United States population-based study. J Am Acad Dermatol. 2021; 85(4):885–892; doi: 10.1016/J.JAAD.2021.02.069
13.
BlaissMS. Socioeconomics of atopic dermatitis—can we afford new treatments? Ann Allergy Asthma Immunol. 2019; 122(4):355–357; doi: 10.1016/j.anai.2018.07.021
14.
YangEJ, BeckKM, SekhonS, et al.The impact of pediatric atopic dermatitis on families: A review. Pediatr Dermatol. 2019; 36(1):66–71; doi: 10.1111/PDE.13727
15.
RamirezFD, ChenS, LanganSM, et al.Assessment of sleep disturbances and exhaustion in mothers of children with atopic dermatitis. JAMA Dermatol. 2019; 155(5):556–563; doi: 10.1001/JAMADERMATOL.2018.5641
16.
ForerE, Golan TriptoI, BariR, et al.Effect of paediatric atopic dermatitis on parental sleep quality. Acta Derm Venereol. 2023; 103:adv00879; doi: 10.2340/ACTADV.V103.4872
17.
LeeHJ, LeeGN, LeeJH, et al.Psychological stress in parents of children with atopic dermatitis: A cross-sectional study from the Korea national health and nutrition examination survey. Acta Derm Venereol. 2023; 103:adv00844; doi: 10.2340/ACTADV.V103.2242
18.
BickersDR, LimHW, MargolisD, et al;Society for Investigative Dermatology. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol. 2006; 55(3):490–500; doi: 10.1016/J.JAAD.2006.05.048
19.
FilanovskyMG, PootongkamS, TamburroJE, et al.The financial and emotional impact of atopic dermatitis on children and their families. J Pediatr. 2016; 169:284–290.e5; doi: 10.1016/J.JPEDS.2015.10.077
20.
AdamsonAS. The economics burden of atopic dermatitis. Adv Exp Med Biol. 2017; 1027:79–92; doi: 10.1007/978-3-319-64804-0_8/TABLES/2
21.
VerboomP, Hakkaart-Van RoijenL, SturkenboomM, et al.The cost of atopic dermatitis in the Netherlands: An international comparison. Br J Dermatol. 2002; 147(4):716–724; doi: 10.1046/J.1365-2133.2002.04964.X
22.
ManciniAJ, KaulbackK, ChamlinSL. The socioeconomic impact of atopic dermatitis in the United States: A systematic review. Pediatr Dermatol. 2008; 25(1):1–6; doi: 10.1111/J.1525-1470.2007.00572.X
23.
KempAS. Cost of illness of atopic dermatitis in children: A societal perspective. Pharmacoeconomics. 2003; 21(2):105–113; doi: 10.2165/00019053-200321020-00003/FIGURES/TAB1
24.
BlewettLA, Rivera DrewJA, KingML, et al.IPUMS Health Surveys: National Health Interview Survey, Version 7.3 [dataset]. IPUMS: Minneapolis, MN; 2023. doi:10.18128/D070.V7.3
YounGM, ShahJP, WeiEX, et al.Perceptions of respect among patients with hearing loss in the United States. Otolaryngol Head Neck Surg. 2023; 169(4):1086–1089; doi: 10.1002/OHN.330
28.
YounGM, SarinKY, ChiouAS, et al.Parental E-Cigarette use and pediatric atopic dermatitis. JAMA Dermatol. 2024; 160(7):780–782; doi: 10.1001/JAMADERMATOL.2024.1283
SilverbergJI, PatelN, ImmaneniS, et al.Assessment of atopic dermatitis using self-report and caregiver report: A multicentre validation study. Br J Dermatol. 2015; 173(6):1400–1404; doi: 10.1111/BJD.14031
StromMA, SilverbergJI. Association between atopic dermatitis and extracutaneous infections in US adults. Br J Dermatol. 2017; 176(2):495–497; doi: 10.1111/BJD.14708
33.
WickhamH, AverickM, BryanJ, et al.Welcome to the tidyverse. JOSS. 2019; 4(43):1686; doi: 10.21105/JOSS.01686
34.
Freedman EllisG, SchneiderB. srvyr: ‘dplyr’-Like Syntax for Summary Statistics of Survey Data. 2022.
35.
A Grammar of Data Manipulation [R package dplyr version 1.1.4]. November 17, 2023. Available from: https://cran.r-project.org/package=dplyr [Last accessed: March23, 2024].
AragonTJ. Epidemiology Tools [R package epitools version 0.5-10.1]. March 22, 2020. Available from: https://cran.r-project.org/package=epitools [Last accessed: March23, 2024].
38.
ZelayaCE, DahlhamerJM, LucasJW, et al.Chronic pain and high-impact chronic pain among U.S. Adults, 2019. NCHS Data Brief. 2020(390):1–8.
39.
HurK, ZhouS, BertelsenC, et al.Health disparities among adults with voice problems in the United States. Laryngoscope. 2018; 128(4):915–920; doi: 10.1002/lary.26947
40.
Min YounG, ShahJP, AgrawalY, et al.Vestibular vertigo and disparities in healthcare access among adults in the United States. Ear Hear. 2023; 44(5):1029–1035; doi: 10.1097/AUD.0000000000001344
41.
ShahJP, YounGM, WeiEX, et al.Disparities in access to health care in adults with sinusitis in the United States. Int Forum Allergy Rhinol. 2023; 13(11):2018–2029; doi: 10.1002/ALR.23167
42.
ChovatiyaR, BegolkaWS, ThibauIJ, et al.The financial burden of out-of-pocket healthcare expenses on caregivers of children with atopic dermatitis in the United States. Skin Health Dis. 2023; 3(1):e191; doi: 10.1002/SKI2.191
43.
HortonS, JohnsonRJ. Improving access to health care for uninsured elderly patients. Public Health Nurs. 2010; 27(4):362–370; doi: 10.1111/J.1525-1446.2010.00866.X
44.
YounEJ, ShinC, HaratianR, et al.Income and insurance status impact access to health care for hip osteoarthritis. Arthrosc Sports Med Rehabil. 2023; 5(4):100747; doi: 10.1016/J.ASMR.2023.05.004
45.
WilperAP, WoolhandlerS, LasserKE, et al.A national study of chronic disease prevalence and access to care in uninsured U.S. adults. Ann Intern Med. 2008; 149(3):170–176; doi: 10.7326/0003-4819-149-3-200808050-00006/ASSET/IMAGES/6TT4.JPG
46.
WrayCM, KhareM, KeyhaniS. Access to care, cost of care, and satisfaction with care among adults with private and public health insurance in the US. JAMA Netw Open. 2021; 4(6):e2110275-e2110275; doi: 10.1001/JAMANETWORKOPEN.2021.10275
47.
GoldmanDP, JoyceGF, ZhengY. Prescription drug cost sharing: Associations with medication and medical utilization and spending and health. JAMA. 2007; 298(1):61–69; doi: 10.1001/JAMA.298.1.61
48.
Fernandez-LazaroCI, AdamsDP, Fernandez-LazaroD, et al.Medication adherence and barriers among low-income, uninsured patients with multiple chronic conditions. Res Social Adm Pharm. 2019; 15(6):744–753; doi: 10.1016/J.SAPHARM.2018.09.006
49.
AdamsA, KluenderR, MahoneyN, et al.The impact of financial assistance programs on health care utilization: Evidence from Kaiser Permanente. Am Econ Rev Insights. 2022; 4(3):389–407; doi: 10.1257/AERI.20210515
50.
NguyenKH, SommersBD. Access and quality of care by insurance type for low-income adults before the affordable care act. Am J Public Health. 2016; 106(8):1409–1415; doi: 10.2105/AJPH.2016.303156
51.
JohnstonSS, CurkendallS, MakenbaevaD, et al.The direct and indirect cost burden of acutecoronary syndrome. J Occup Environ Med. 2011; 53(1):2–7; doi: 10.1097/JOM.0B013E31820290F4
52.
BeboB, CintinaI, LaroccaN, et al.The economic burden of multiple sclerosis in the United States: Estimate of direct and indirect costs. Neurology. 2022; 98(18):E1810–E1817; doi: 10.1212/WNL.0000000000200150/ASSET/D6F80E65-B74C-4CD0-8E1B-55BF4CB9D4E7/ASSETS/GRAPHIC/14TTU1.JPEG
53.
LiX, XuX, LiJ, et al.Direct and indirect costs of allergic and non-allergic rhinitis to adults in Beijing, China. Clin Transl Allergy. 2022; 12(4):e12148; doi: 10.1002/CLT2.12148
54.
de CourvilleC, CadaretteSM, WissingerE, et al.The economic burden of influenza among adults aged 18 to 64: A systematic literature review. Influenza Other Respir Viruses. 2022; 16(3):376–385; doi: 10.1111/IRV.12963
55.
ChristensenMK, LimCCW, SahaS, et al.The cost of mental disorders: A systematic review. Epidemiol Psychiatr Sci. 2020; 29:e161; doi: 10.1017/S204579602000075X
56.
IragorriN, de OliveiraC, FitzgeraldN, et al.The indirect cost burden of cancer care in Canada: A systematic literature review. Appl Health Econ Health Policy. 2021; 19(3):325–341; doi: 10.1007/S40258-020-00619-Z/FIGURES/2
57.
Van GennepS, EversSW, RietdijkST, et al.High disease burden drives indirect costs in employed inflammatory bowel disease patients: The WORK-IBD Study. Inflamm Bowel Dis. 2021; 27(3):352–363; doi: 10.1093/IBD/IZAA082
58.
KellyEB. Leaving and losing jobs: Resistance of rural low-income mothers. J Poverty. 2005; 9(1):83–103; doi: 10.1300/J134V09N01_05
59.
Clemans-CopeL, PerryCD, KenneyGM, et al.Access to and use of paid sick leave among low-income families with children. Pediatrics. 2008; 122(2):e480-486–e486; doi: 10.1542/PEDS.2007-3294
60.
DeRigneLA, Stoddard-DareP, QuinnL. Workers without paid sick leave less likely to take time off for illness or injury compared to those with paid sick leave. Health Aff (Millwood). 2016; 35(3):520–527; doi: 10.1377/HLTHAFF.2015.0965/ASSET/IMAGES/LARGE/2015.0965FIGEX3.JPEG
61.
SlopenM. The impact of paid sick leave mandates on women’s health. Soc Sci Med. 2023; 323:115839; doi: 10.1016/J.SOCSCIMED.2023.115839
MorarN, Willis-OwenSAG, MoffattMF, et al.The genetics of atopic dermatitis. J Allergy Clin Immunol. 2006; 118(1):24–34; doi: 10.1016/J.JACI.2006.03.037
64.
OtsukaA, NomuraT, RerknimitrP, et al.The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis. Immunol Rev. 2017; 278(1):246–262; doi: 10.1111/IMR.12545
